Investigated Individuals and Frequency of Detection of Clonal TCRγ Rearrangements
| Diagnosis . | Detection of Clonality . | |||||
|---|---|---|---|---|---|---|
| . | Blood Specimens . | Skin Specimens . | . | . | ||
| . | No.* . | % . | No.* . | % . | . | . |
| CTCL | ||||||
| MF IA | 6/13 | 46.2 | 9/12 | 75.0 | ||
| MF IB | 15/27 | 55.6 | 17/24 | 70.8 | ||
| MF II-IV | 5/5 | 100 | 3/4 | 75.0 | ||
| SS | 6/7 | 85.7 | 3/4 | 75.0 | ||
| Pleomorphic | 10/13 | 76.9 | 12/12 | 100 | ||
| Unclassified | 3/4 | 75.0 | 2/2 | 100 | ||
| Total | 45/69 | 65.2 | 46/58 | 79.3 | ||
| Controls | ||||||
| PV | 1/20 | 5.0 | 0/20 | 0 | ||
| AD | 0/20 | 0 | 0/20 | 0 | ||
| HV | 0/20 | 0 | nt | nt | ||
| Total | 1/60 | 1.7 | 0/40 | 0 | ||
| Diagnosis . | Detection of Clonality . | |||||
|---|---|---|---|---|---|---|
| . | Blood Specimens . | Skin Specimens . | . | . | ||
| . | No.* . | % . | No.* . | % . | . | . |
| CTCL | ||||||
| MF IA | 6/13 | 46.2 | 9/12 | 75.0 | ||
| MF IB | 15/27 | 55.6 | 17/24 | 70.8 | ||
| MF II-IV | 5/5 | 100 | 3/4 | 75.0 | ||
| SS | 6/7 | 85.7 | 3/4 | 75.0 | ||
| Pleomorphic | 10/13 | 76.9 | 12/12 | 100 | ||
| Unclassified | 3/4 | 75.0 | 2/2 | 100 | ||
| Total | 45/69 | 65.2 | 46/58 | 79.3 | ||
| Controls | ||||||
| PV | 1/20 | 5.0 | 0/20 | 0 | ||
| AD | 0/20 | 0 | 0/20 | 0 | ||
| HV | 0/20 | 0 | nt | nt | ||
| Total | 1/60 | 1.7 | 0/40 | 0 | ||
Number of specimens containing a dominant T-cell clone v investigated samples.